Cerevel Therapeutics Shares Are Trading Lower Amid Unconfirmed Rumors of a Recommendation Memo From FTC Staff to Challenge the AbbVie Merger.
Cerevel Therapeutics Shares Are Trading Lower Amid Unconfirmed Rumors of a Recommendation Memo From FTC Staff to Challenge the AbbVie Merger.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.